AI Assisted Cervical Cancer Screening for Cytology Samples in Developing Countries
Love Panta, Suraj Prasai, Karishma Malla Vaidya, Shyam Shrestha, Suresh Manandhar
TL;DR
Cervical cancer screening in developing countries is hampered by labor-intensive Liquid-Based Cytology and limited access to expert pathologists. The authors propose an end-to-end pipeline that combines a motorized, low-cost microscope with AI: an image-stitching module builds panoramic cytology views, a human-in-the-loop cellpose2.0 segmentation refines cell masks, and a Convolutional Vision Transformer (CvT-13) performs five-class cervical cell classification trained on the SIPaKMeD dataset. Key contributions include the CYTOCERVIX dataset collected in Nepal, the demonstrated effectiveness of CYTOCERVIX_cyto2 and combined_cyto2 segmentation variants, and a high-performing CvT-13 classifier achieving 99.68% accuracy with an AUC of approximately 1.0 on SIPaKMeD. Together, these results indicate a scalable, affordable screening approach suitable for low-resource settings, and the authors plan to publicly release their segmentation dataset for broader research use.
Abstract
Cervical cancer remains a significant health challenge, with high incidence and mortality rates, particularly in transitioning countries. Conventional Liquid-Based Cytology(LBC) is a labor-intensive process, requires expert pathologists and is highly prone to errors, highlighting the need for more efficient screening methods. This paper introduces an innovative approach that integrates low-cost biological microscopes with our simple and efficient AI algorithms for automated whole-slide analysis. Our system uses a motorized microscope to capture cytology images, which are then processed through an AI pipeline involving image stitching, cell segmentation, and classification. We utilize the lightweight UNet-based model involving human-in-the-loop approach to train our segmentation model with minimal ROIs. CvT-based classification model, trained on the SIPaKMeD dataset, accurately categorizes five cell types. Our framework offers enhanced accuracy and efficiency in cervical cancer screening compared to various state-of-art methods, as demonstrated by different evaluation metrics.
